Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date.

Drugs - 12 Feb 2010

Becq Frédéric

Abstract excerpt

This article considers the issue of personalized drug discovery for the orphan disease cystic fibrosis (CF) to deliver a candidate for therapeutic development. CF is a very complicated disease due to numerous anomalies of the gene leading to progressive severity and morbidity. Despite extensive r...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Discovery

Share to Drug Evaluation, Preclinical

Share to Drugs, Investigational

Share to Pneumonia

Share to Precision Medicine

Source

Identifiers

PMID: 20166764
DOI: 10.2165/11316160-000000000-00000

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20166764-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date.PMID 20166764Read ↗

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesSemantic proximity Read ↗

Discovery of CFTR modulators for the treatment of cystic fibrosis.Semantic proximity Read ↗

Emerging drug treatments for cystic fibrosis.Semantic proximity Read ↗

The revolution of personalized pharmacotherapies for cystic fibrosis: what does the future hold?Semantic proximity Read ↗

Emerging medicines to improve the basic defect in cystic fibrosis.Semantic proximity Read ↗

Progress towards next-generation therapeutics for cystic fibrosis.Semantic proximity Read ↗

Molecular basis of cystic fibrosis: from bench to bedsideSemantic proximity Read ↗

New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator.Semantic proximity Read ↗

Cystic fibrosis: current therapeutic targets and future approaches.Semantic proximity Read ↗

Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation.Semantic proximity Read ↗

Repairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator.Semantic proximity Read ↗

Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.